Menstrual Cycle Clinical Trial
Official title:
Cyclic Variation in Micronutrient Concentrations and Plasma Volume in Reproductive-Age Women
The overall goal of this study is to examine the influence of the menstrual cycle on micronutrient concentrations and plasma volume in healthy, reproductive-age women with regular cycles. The investigators aim to quantify changes in micronutrient biomarker concentrations (zinc, copper, iron, and vitamin A) and plasma volume across the menstrual cycle in healthy women.
This is a longitudinal prospective study wherein all subjects will be examined at three time
points within a single menstrual cycle: the early follicular phase (~day 2), periovulation
(~day 12), and the luteal phase (~day 21)—based on an approximate 28-day cycle length. The
actual days of visits will be adjusted for the length of the woman's menstrual cycle. At
least 35 non-pregnant women ages 18 to 44 years will be recruited as a convenience sample of
eligible women in the State College area and surrounding towns within Centre County,
Pennsylvania, USA. If a woman responds to the recruitment, she will be asked a set of
pre-screening questions to determine eligibility. If a woman is thought to be eligible, she
will complete a verbal consent for the screening (and the actual screening will occur at the
first visit). Then she will be invited to the Clinical Research Center (CRC), a service unit
in Penn State's Clinical and Translational Science Institute, for full screening and
participation. Before scheduling the visit, the woman will be asked for the expected date of
the first day of her next menstrual period. The woman will then be tentatively scheduled for
her first visit at the CRC approximately 1 day after this date (avoiding weekend days).
As part of the preparation for study visits, the woman will be asked to fast the night before
her visit. Women will also be asked to avoid alcohol intake for 12 hours preceding their
scheduled visits to the CRC, and to drink plenty of water. On the morning of the visit, the
woman will arrive at the CRC, go through complete screening (including height, weight, blood
pressure, and pregnancy test). If eligible for the main study, the woman will then go through
the consent process for the main study. If the woman gives consent to participate, the
investigators will then proceed with study measurements (including a questionnaire and body
composition measurement).
Following these measurements, the study nurse or doctor will insert an IV into the vein of
one arm and an initial baseline blood draw will be taken (~15-20 ml, in several tubes). This
blood will be used for biomarker assessment (hemoglobin, hematocrit, vitamins, minerals, etc)
and as a blank sample before the dye injection. Next, indocyanine green (ICG) will be used to
measure plasma volume. A solution will be prepared using 25 mg of ICG lyophilized powder
dissolved in 10 ml of sterile water. The investigators will draw enough solution to inject
0.25 mg/kg body weight into a syringe. The syringe will be weighed to measure the exact
amount. Then the solution will be injected via the IV and flushed with saline. After 2
minutes, five ~3 ml blood samples will be drawn at intervals of 45 seconds over the next 3
minutes. Expected total volume of blood drawn at the visit will be <35 mL.
At the end of this first visit the participant will be given a home-based fertility monitor
to take home to track her cycle. She will be instructed on how to use the monitor at home but
the research team will maintain contact with her on a regular basis to ensure that she is
using the monitor correctly. She will conduct a daily urine test with the monitor, which uses
urine hormone concentrations to track the stage of the menstrual cycle for the participants
by displaying low, high, or peak fertility. The second and third visits will be scheduled
using an algorithm that takes into consideration the woman's menstrual cycle length and
results from a home-based urine fertility monitor.
At the third visit, the participant will return the monitor to the CRC and the urine test
results, which are stored in the monitor, will be retrieved. At the end of the third visit
her study participation is complete but the investigators will keep in contact with her to
record the first date of her next cycle (to calculate actual cycle length).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03708692 -
Menstrual Cycle Phases on Recovery and Cognitive Function
|
||
Recruiting |
NCT05683119 -
The Effect of Menstrual Cycle and Oral Contraceptive Pill Phase on Aspects of Exercise Physiology
|
N/A | |
Completed |
NCT03708679 -
Effects of Menstrual Cycle on Preoperative Anxiety
|
||
Recruiting |
NCT05936424 -
Menstrual Cycle Phase Based Training
|
N/A | |
Recruiting |
NCT05802277 -
Characterization of the Mechanical Properties of the Hamstring Muscle Group in Female.
|
N/A | |
Recruiting |
NCT03299179 -
The Effects of the Female Hormones on Cerebral Perfusion
|
||
Not yet recruiting |
NCT05088122 -
Hormonal Effect of Different Menstrual Phases on Dynamic Balance in Postpubertal Females
|
||
Recruiting |
NCT06377306 -
Identifying Periods of High Training Load Considering the Menstrual Cycle Phases in Elite and Non-elite Female Athletes
|
||
Recruiting |
NCT06072391 -
Investigating the Endocrine-metabolic-immunological Axis During the Female Menstrual Cycle by Functional Genomics
|
||
Completed |
NCT06086262 -
Hand Grip Strength in Athletic and Non-Athletic Girls at Different Phases of Menstrual Cycle
|
||
Recruiting |
NCT04196595 -
Apple Women's Health Study
|
||
Recruiting |
NCT06214442 -
Effects of the Menstrual Cycle on Triceps Surae Properties in Women
|
||
Not yet recruiting |
NCT06426459 -
Social Media Usage in Adolescent Girls
|
||
Recruiting |
NCT06365515 -
Dopamine, Reward Learning and Sex Hormones
|
N/A | |
Active, not recruiting |
NCT05347667 -
Menstrual Cycle Phase Muscle Protein Synthesis
|
N/A | |
Completed |
NCT04286828 -
Position Sense, Balance, and Dual Task Performance at the Menstrual Cycle in Females With Multiple Sclerosis
|
||
Completed |
NCT05576740 -
Influence of Menstrual Cycle Stages on Female Athletes
|
||
Completed |
NCT00456222 -
Impact of Sleep Disruption on the Menstrual Cycle
|
N/A | |
Completed |
NCT00128726 -
The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function
|
Phase 1 | |
Not yet recruiting |
NCT06060574 -
Menstrual Cycle and Platelet-rich Fibrin
|